IS DARATUMUMAB ELIMINATED IN THE URINE OF PATIENTS WITH AL AMYLOIDOSIS?

被引：0
|
作者：
Gil Alos, D. [1 ]
Cuevas Gomez, D. [2 ]
Colmenares Gil, R. [1 ]
Gil Manso, R. [1 ]
Iniguez Garcia, R. [1 ]
Zamanillo Herrero, I [1 ]
Poza Santaella, M. [1 ]
Puerta Fonolla, P. [2 ]
Sanchez Pina, J. M. [1 ]
Martinez Lopez, J. [1 ]
机构：
[1] Hosp 12 Octubre, Serv Hematol & Hemoterapia, Madrid, Spain
[2] Hosp 12 Octubre, Serv Bioquim & Anal Clin, Madrid, Spain
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-030
引用
下载
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [21] Safety and Efficacy of Subcutaneous Daratumumab in Systemic AL Amyloidosis
    Hughes, Michael Sang
    Lentzsch, Suzanne
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 1063 - 1074
  • [22] Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis
    Kaufman, Gregory P.
    Schrier, Stanley L.
    Lafayette, Richard A.
    Arai, Sally
    Witteles, Ronald M.
    Liedtke, Michaela
    BLOOD, 2017, 130 (07) : 900 - 902
  • [23] DARATUMUMAB IN HEAVILY PRETREATED, TRANSPLANT INELIGIBLE, AL AMYLOIDOSIS PATIENTS: A SINGLE CENTRE EXPERIENCE
    Riva, M.
    Scapinello, G.
    Ammirati, L.
    Lessi, F.
    Branca, A.
    Zambello, R.
    Piazza, F.
    Semenzato, G.
    Berno, T.
    HAEMATOLOGICA, 2019, 104 : 64 - 65
  • [24] Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease
    Kastritis, Efstathios
    Rousakis, Pantelis
    Kostopoulos, Ioannis, V
    Gavriatopoulou, Maria
    Theodorakakou, Foteini
    Fotiou, Despina
    Dialoupi, Ioanna
    Migkou, Magdalini
    Roussou, Maria
    Kanellias, Nikolaos
    Tselegkidi, Maria-Irini
    Eleutherakis-Papaiakovou, Evangelos
    Papanikolaou, Asimina
    Gakiopoulou, Charikleia
    Psimenou, Erasmia
    Spyropoulou-Vlachou, Marylin
    Gatou, Anastasia
    Terpos, Evangelos
    Tsitsilonis, Ourania
    Dimopoulos, Meletios A.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2021, 28 (04): : 259 - 266
  • [25] DARATUMUMAB IN MONOTHERAPY IN PATIENTS WITH REFRACTORY/ RELAPSE AMYLOIDOSIS
    Tamariz Amador, L. E.
    Riesgo Garcia, A.
    Hernandez Santamaria, T.
    Villar Fernandez, S.
    Marcos Jubilar, M.
    Riego Repullo, V
    Shangutov, O.
    Iglesias Colino, E.
    Rodriguez Otero, P.
    Salterain Gonzalez, N.
    Gavira Gomez, J. J.
    San Miguel Izquierdo, J. F.
    Lecumberri Villamediana, R.
    HAEMATOLOGICA, 2018, 103 : 118 - 118
  • [26] Daratumumab as successful initial therapy for AL amyloidosis with nerve involvement
    Deshpande, Shweta
    Gertz, Morie A.
    Dispenzieri, Angela
    Kumar, Shaji S.
    Parikh, Sameer A.
    Muchtar, Eli
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1752 - 1755
  • [27] The UK experience of daratumumab monotherapy in relapsed systemic AL amyloidosis
    Cohen, O.
    Brodermann, M. H.
    Blakeney, I. J.
    Mahmood, S.
    Sachchithanantham, S.
    Ravichandran, S.
    Lachmann, H.
    Whelan, C.
    Shah, R.
    Cheesman, S.
    Worthington, S.
    Hawkins, P.
    Gillmore, J.
    Wechalekar, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 116 - 117
  • [28] Organ responses with daratumumab therapy in previously treated AL amyloidosis
    Chung, Alfred
    Kaufman, Gregory P.
    Sidana, Surbhi
    Eckhert, Erik
    Schrier, Stanley L.
    Lafayette, Richard A.
    Arai, Sally
    Witteles, Ronald M.
    Liedtke, Michaela
    BLOOD ADVANCES, 2020, 4 (03) : 458 - 466
  • [29] Treatment with daratumumab in patients with relapsed/refractory AL amyloidosis: a multicentric retrospective study and review of the literature
    Lecumberri, Ramon
    Krsnik, Isabel
    Askari, Elham
    Sirvent, Maialen
    Gonzalez-Perez, Marta S.
    Escalante, Fernando
    Pradillo, Virginia
    Tamariz, Luis E.
    Canovas, Veronica
    Alegre, Adrian
    Gironella, Mercedes
    Gonzalez-Garcia, Maria E.
    Infante, Maria S.
    Lakhwani, Sunil
    Martinez-Bilbao, Cristina
    Dourdil, Victoria
    Ramirez-Payer, Angel
    Sarra, Jose
    Cibeira, M. Teresa
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2020, 27 (03): : 163 - 167
  • [30] Rapid Hematologic and Organ Responses with Daratumumab, Bortezomib and Dexamethasone in Patients with Relapsed/Refractory AL Amyloidosis
    Lee, Sarah S.
    Rosko, Nathaniel
    Patel, Bhumika J.
    Waldron, Madeline
    Tomer, Jackie
    Goldman, Roman
    Karam, Mary Ann
    Reed, Janice
    Faiman, Beth M.
    Hamilton, Kimberly
    Mathur, Saveta
    Samaras, Christy J.
    Valent, Jason
    BLOOD, 2018, 132
12345